Page 1
His ADHD symptoms can be disruptive, but there’s a great kid in there.
Now there’s a new way to help him out…
New for the treatment of ADHD

Spread (pages 2 and 3):
Introducing once-daily Intuniv
A new way to reach the kid within
Intuniv demonstrated significant improvement in ADHD symptoms, which can be disruptive.
New for the treatment of ADHD

To see all of the ads from this campaign, click here

Brand name: intuniv
Generic name/category: Guanfacine, Antihypertensive agents, Guanidines, Alpha-adrenergic agonists
Company: Shire
Country/Market: USA, North America
Indication(s)/use: attention-deficit hyperactivity disorder (ADHD)
Target: Healthcare Professionals (HCP)
Tagline: A new way to reach the kid within
Medium: Print ad
Size/duration: Three-page spread
Publication/Aired: Contemporary Pediatrics – November 2009

To see all of this brand’s ads on AdPharm, click here

Click here to see the details and full-size version of this ad on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click here to see the original post on AdPharm

Visit AdPharm.net for more pharmaceutical ads

Click on the image to see the full-sized ad and get all the info on AdPharm.

38 more Crestor ads on AdPharm, click here

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click on images to view ad details and full-size version on AdPharm

To see all of this brand’s ads on AdPharm, click here

Click on image to view ad details and full-size version on AdPharm

To see all of this brand’s ads on AdPharm, click here

Why build a window when you really need a door?
Co-pay challenges. Patient loyalty. Buy & Bill brands. Physician Access.

Brand name: trialcard
Generic name/category: Service industry, corporate
Company: Trialcard
Country/Market: USA, North America
Indication(s)/use: Patient compliance, Co-pay
Target: Trade
Medium: Print ad
Size/duration: single-page
Publication/Aired: Pharmaceutical Executive – August 2009

Outoa kipua, johon mik?€?€n ei tunnu auttavan?

Polttelua, pistely?€ tai alasel?€st?€ pohkeeseen s?€teilev?€?€ kipua. Joskus pelkk?€ vaatteen hipaisu voi tuntua kivuliaalta. Yhteist?€ n?€ille oudoille kivuntuntemuksille on se, ett?€ yleisesti k?€ytetyist?€ kipul?€?€kkeist?€ ei ole mit?€?€n apua.

Edell?€ kuvatut oireet voivat viitata hermovauriokipuun eli neuropaattiseen kipuun.

Onneksi sit?€ voidaan hoitaa. Kysy l?€?€k?€rilt?€si tai katso lis?€tietoja osoitteessa www.neuropaattinenkipu.fi

Jonkun on oltava ensimm?€inen.

Strange pain, for which nothing seems to help?
Burning, tingling, or pain radiating to lower back. Sometimes touching a simple garment may seem painful. What these strange pains, the usual pain medicines does not seem to be of any help.
Described above symptoms may indicate nerve damage causing pain or neuropathic pain.
Fortunately, it can be treated. Ask your doctor or get more details, visit www.neuropaattinenkipu.fi

Someone has to be the first.

Brand name: Pfizer
Generic name/category: corporate ad, disease awareness
Company: Pfizer
Country/Market: Finland, Europe
Indication(s)/use: neuropathic pain
Target: Consumers (DTC)
Tagline: Jonkun on oltava ensimm?€inen – Someone has to be the first
Medium: Print ad
Size/duration: double-page spread
Publication/Aired: Kauneus And Terveys – December 2006

To see all of this brand's ads on AdPharm, click here
0 views
Aug 27, 2009

Visit AdPharm.net for more pharmaceutical ads